A Study to Learn More About the Safety and Effects of Felzartamab in Adults With Lupus Nephritis Aged 18 to 75 Years Old
Clinical trial NCT06064929 · COMPLETED
Trial details
- NCT number
- NCT06064929
- Sponsor
- HI-Bio, A Biogen Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-01
- Primary completion
- 2026-06-24
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.